During the past decade, Tokai University School of Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokai University School of Medicine" #1 sponsor was "Celgene" with 4 trials, followed by "Comprehensive Support Project for Oncology Research" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Haruhiko Fukuda" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokai University School of Medicine" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Tokai University School of Medicine" are "Breast Cancer" (2 trials), "Advanced Solid Tumors or Triple-negative Breast Cancer" (1 trials), "Anemia" (1 trials), "Carcinoma, Squamous Cell" (1 trials) and "Cerebral Infarction" (1 trials). Many other conditions were trialed in "Tokai University School of Medicine" in a lesser frequency.

Most popular intervention types in "Tokai University School of Medicine" are "Drug" (10 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials), "(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2＋Surgery" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokai University School of Medicine" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Tokai University School of Medicine". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tokai University School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tokai University School of Medicine, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".